Share
12,415 Posts.
lightbulb Created with Sketch. 6389
clock Created with Sketch. 15/11/17
20:38
Share
Originally posted by whytee
↑
Yes I am a doctor and I know several of the people involved with the company and the trial. Although medicine classifies diseases like cancer or neuro-degenerative diseases according to the organ they occur in or their behaviour, in fact the genetic basis may be quite diverse meaning they respond to different treatments. While it would have been amazingly good for all bowel cancer to respond well to a certain treatment, we have come to realise that some treatments for what appears to be the same disease work better in sub-classes of patients. So I never expected all of the patients to respond well to NTcell.There is no way to be sure they are suffering from exactly the same disease.
Expand
Time is going to be resource that LCT require, and time is money,, that 2 month delay from the 3rd party provider seems even more valuable now ,,,If LCT can generate a business plan , demonstrating what actual dollar returns can be attached to their technology , then they may be able to attract new investors, be aware Traders will churn this low and volatile SP for the next couple of months
(20min delay)